Cargando…

Clinical Features of Mycetoma and the Appropriate Treatment Options

Mycetoma is a chronic, suppurative and debilitating granulomatous infection seen mainly in tropical and subtropical areas and is now declared as a neglected tropical disease by the World Health Organization. The clinical diagnosis is usually characterized by a classical triad of localized swelling,...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Pooja, Jagati, Ashish, Rathod, Santoshdev P, Kalra, Kirti, Patel, Shefali, Chaudhari, Malay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275212/
https://www.ncbi.nlm.nih.gov/pubmed/34267575
http://dx.doi.org/10.2147/RRTM.S282266
_version_ 1783721687822368768
author Agarwal, Pooja
Jagati, Ashish
Rathod, Santoshdev P
Kalra, Kirti
Patel, Shefali
Chaudhari, Malay
author_facet Agarwal, Pooja
Jagati, Ashish
Rathod, Santoshdev P
Kalra, Kirti
Patel, Shefali
Chaudhari, Malay
author_sort Agarwal, Pooja
collection PubMed
description Mycetoma is a chronic, suppurative and debilitating granulomatous infection seen mainly in tropical and subtropical areas and is now declared as a neglected tropical disease by the World Health Organization. The clinical diagnosis is usually characterized by a classical triad of localized swelling, underlying sinus tracts, and production of grains or granules, but unusual presentations are also seen. It is classified into eumycetoma caused by the fungus, and actinomycetoma caused by the bacteria. The clinical presentation of both is almost similar and a definite diagnosis is essential before starting the treatment as it differs for both. Surgical debulking followed by a prolonged course of medical therapy now forms the mainstay of treatment due to the long course of the disease and suboptimal response. This review focuses on the various usual as well as unusual clinical presentations of mycetoma, established treatment regimens as well as recent changes in the mode of administration of drugs and newer drugs for mycetoma.
format Online
Article
Text
id pubmed-8275212
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82752122021-07-14 Clinical Features of Mycetoma and the Appropriate Treatment Options Agarwal, Pooja Jagati, Ashish Rathod, Santoshdev P Kalra, Kirti Patel, Shefali Chaudhari, Malay Res Rep Trop Med Review Mycetoma is a chronic, suppurative and debilitating granulomatous infection seen mainly in tropical and subtropical areas and is now declared as a neglected tropical disease by the World Health Organization. The clinical diagnosis is usually characterized by a classical triad of localized swelling, underlying sinus tracts, and production of grains or granules, but unusual presentations are also seen. It is classified into eumycetoma caused by the fungus, and actinomycetoma caused by the bacteria. The clinical presentation of both is almost similar and a definite diagnosis is essential before starting the treatment as it differs for both. Surgical debulking followed by a prolonged course of medical therapy now forms the mainstay of treatment due to the long course of the disease and suboptimal response. This review focuses on the various usual as well as unusual clinical presentations of mycetoma, established treatment regimens as well as recent changes in the mode of administration of drugs and newer drugs for mycetoma. Dove 2021-07-08 /pmc/articles/PMC8275212/ /pubmed/34267575 http://dx.doi.org/10.2147/RRTM.S282266 Text en © 2021 Agarwal et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Agarwal, Pooja
Jagati, Ashish
Rathod, Santoshdev P
Kalra, Kirti
Patel, Shefali
Chaudhari, Malay
Clinical Features of Mycetoma and the Appropriate Treatment Options
title Clinical Features of Mycetoma and the Appropriate Treatment Options
title_full Clinical Features of Mycetoma and the Appropriate Treatment Options
title_fullStr Clinical Features of Mycetoma and the Appropriate Treatment Options
title_full_unstemmed Clinical Features of Mycetoma and the Appropriate Treatment Options
title_short Clinical Features of Mycetoma and the Appropriate Treatment Options
title_sort clinical features of mycetoma and the appropriate treatment options
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275212/
https://www.ncbi.nlm.nih.gov/pubmed/34267575
http://dx.doi.org/10.2147/RRTM.S282266
work_keys_str_mv AT agarwalpooja clinicalfeaturesofmycetomaandtheappropriatetreatmentoptions
AT jagatiashish clinicalfeaturesofmycetomaandtheappropriatetreatmentoptions
AT rathodsantoshdevp clinicalfeaturesofmycetomaandtheappropriatetreatmentoptions
AT kalrakirti clinicalfeaturesofmycetomaandtheappropriatetreatmentoptions
AT patelshefali clinicalfeaturesofmycetomaandtheappropriatetreatmentoptions
AT chaudharimalay clinicalfeaturesofmycetomaandtheappropriatetreatmentoptions